found that the level of glucagon-like peptide-1 (GLP-1) was increased in pancreatic cancer cachexia patients (90), GLP-1 appears to trigger satiety and inhibit food intake through molecular regulation in the hypothalamus (91). Here, GCG is linked to pancreatic neoplasm.